loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) of Nafamostat Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Email Product
    Menu

    Nafamostat

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    MARKET PLACE

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Temad- We think of world-class quality.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Aurore Life Sciences (1)

    02 Katsura Chemical (1)

    filter

    01 NAFAMOSTAT MESILATE JP (1)

    02 NAFAMOSTAT MESILATE-K (USAN: NAFAMOSTAT MESYLATE) (1)

    filter

    01 India (1)

    02 Japan (1)

    filter

    01 Active (2)

    filter

    01 Blank (2)

    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    AURORE LIFE SCIENCES PRIVATE LTD

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    NAFAMOSTAT MESILATE JP

    PDF Supplier PDF
    URL Supplier Web Content
    36046
    Active
    2021-07-03
    N/A
    II
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    KATSURA CHEMICAL CO LTD

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Japan
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      NAFAMOSTAT MESILATE-K (USAN: NAFAMOSTAT MESYLATE)

      PDF Supplier PDF
      URL Supplier Web Content
      36042
      Active
      2021-12-09
      N/A
      II
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for 81525-10-2 / Nafamostat API manufacturers, exporters & distributors?

      Nafamostat manufacturers, exporters & distributors 1

      72

      PharmaCompass offers a list of Nafamostat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nafamostat manufacturer or Nafamostat supplier for your needs.

      Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nafamostat manufacturer or Nafamostat supplier.

      PharmaCompass also assists you with knowing the Nafamostat API Price utilized in the formulation of products. Nafamostat API Price is not always fixed or binding as the Nafamostat Price is obtained through a variety of data sources. The Nafamostat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

      API | Excipient name

      Nafamostat

      Synonyms

      81525-10-2, Nafamostat [inn], Nafamstat, (6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate, Chembl273264, Y25lq0h97d

      Cas Number

      81525-10-2

      Unique Ingredient Identifier (UNII)

      Y25LQ0H97D

      About Nafamostat

      Nafamostat is a broad-spectrum, synthetic serine protease inhibitor, with anticoagulant, anti-inflammatory, mucus clearing, and potential antiviral activities. Upon administration, nafamostat inhibits the activities of a variety of proteases, including thrombin, plasmin, kallikrein, trypsin, and Cl esterase in the complement system, and factors VIIa, Xa, and XIIa in the coagulation system. Although the mechanism of action of nafamostat is not fully understood, trypsinogen activation in the pancreas is known to be a trigger reaction in the development of pancreatitis. Nafamostat blocks the activation of trypsinogen to trypsin and the inflammatory cascade that follows. Nafamostat may also decrease epithelial sodium channel (ENaC) activity and increase mucus clearance in the airways. ENaC activity is increased in cystic fibrosis. In addition, nafamostat may inhibit the activity of transmembrane protease, serine 2 (TMPRSS2), a host cell serine protease that mediates viral cell entry for influenza virus and coronavirus, thereby inhibiting viral infection and replication.

      Nafamostat Manufacturers

      A Nafamostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nafamostat, including repackagers and relabelers. The FDA regulates Nafamostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nafamostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

      click here to find a list of Nafamostat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

      Nafamostat Suppliers

      A Nafamostat supplier is an individual or a company that provides Nafamostat active pharmaceutical ingredient (API) or Nafamostat finished formulations upon request. The Nafamostat suppliers may include Nafamostat API manufacturers, exporters, distributors and traders.

      click here to find a list of Nafamostat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

      Nafamostat USDMF

      A Nafamostat DMF (Drug Master File) is a document detailing the whole manufacturing process of Nafamostat active pharmaceutical ingredient (API) in detail. Different forms of Nafamostat DMFs exist exist since differing nations have different regulations, such as Nafamostat USDMF, ASMF (EDMF), JDMF, CDMF, etc.

      A Nafamostat DMF submitted to regulatory agencies in the US is known as a USDMF. Nafamostat USDMF includes data on Nafamostat's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nafamostat USDMF is kept confidential to protect the manufacturer’s intellectual property.

      click here to find a list of Nafamostat suppliers with USDMF on PharmaCompass.

      Nafamostat Manufacturers | Traders | Suppliers

      Nafamostat Manufacturers, Traders, Suppliers 1
      50

      We have 2 companies offering Nafamostat

      Get in contact with the supplier of your choice:

      1. Aurore Life Sciences
      2. Katsura Chemical
      Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
      For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
      Post Enquiry
      POST ENQUIRY